glp-1 drugs and anxiety The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 diabetes drugs could stop
Description
doi: 10.1111/1753-0407.12198 172 RosenstockJSorliCHTrautmannMEMoralesCWendischUDaileyGet al
This rigorous process ensures every article reflects current medical standards and is regularly updated to include the latest healthcare insights
[DOI] [PMC free article] [PubMed] [Google Scholar] 523.Macfarlane W.M., Frayling T.M., Ellard S., Evans J.C., Allen L.I., Bulman M.P
FTC Affiliate Disclosure and Publisher Responsibility: This article contains affiliate links
